OCBV
Ownership Capital B.V.’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140M | Sell |
1,786,254
-567,094
| -24% | -$44.4M | 8.12% | 2 |
|
|
2025
Q1 | $171M | Sell |
2,353,348
-438,917
| -16% | -$31.8M | 7.82% | 2 |
|
|
2024
Q4 | $207M | Sell |
2,792,265
-200,754
| -7% | -$14.9M | 7.6% | 2 |
|
|
2024
Q3 | $198M | Buy |
2,993,019
+34,597
| +1% | +$2.28M | 6.31% | 5 |
|
|
2024
Q2 | $273M | Sell |
2,958,422
-271,533
| -8% | -$25.1M | 7.39% | 3 |
|
|
2024
Q1 | $309M | Sell |
3,229,955
-259,960
| -7% | -$24.8M | 7.06% | 5 |
|
|
2023
Q4 | $266M | Buy |
3,489,915
+613,817
| +21% | +$46.8M | 5.94% | 5 |
|
|
2023
Q3 | $199M | Sell |
2,876,098
-776,875
| -21% | -$53.8M | 4.99% | 11 |
|
|
2023
Q2 | $345M | Sell |
3,652,973
-451,579
| -11% | -$42.6M | 6.04% | 7 |
|
|
2023
Q1 | $340M | Sell |
4,104,552
-50,831
| -1% | -$4.21M | 5.97% | 7 |
|
|
2022
Q4 | $310M | Sell |
4,155,383
-31,556
| -0.8% | -$2.35M | 6.08% | 8 |
|
|
2022
Q3 | $346M | Sell |
4,186,939
-309,950
| -7% | -$25.6M | 6.69% | 2 |
|
|
2022
Q2 | $428M | Buy |
4,496,889
+190,982
| +4% | +$18.2M | 7.35% | 3 |
|
|
2022
Q1 | $507M | Buy |
4,305,907
+231,667
| +6% | +$27.3M | 6.69% | 2 |
|
|
2021
Q4 | $528M | Sell |
4,074,240
-992,336
| -20% | -$129M | 5.71% | 7 |
|
|
2021
Q3 | $574M | Buy |
5,066,576
+160,960
| +3% | +$18.2M | 6.5% | 3 |
|
|
2021
Q2 | $508M | Buy |
4,905,616
+119,230
| +2% | +$12.3M | 5.91% | 4 |
|
|
2021
Q1 | $400M | Buy |
4,786,386
+658,447
| +16% | +$55.1M | 5.21% | 11 |
|
|
2020
Q4 | $377M | Buy |
4,127,939
+828,870
| +25% | +$75.6M | 5.31% | 8 |
|
|
2020
Q3 | $263M | Buy |
+3,299,069
| New | +$263M | 5.47% | 7 |
|